Haleon Pakistan Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, HALEON's sales fell 13% to Rs 10.1bn, from Rs 11.6bn, and profit after tax rose 3% to Rs 1.7bn, from Rs 1.6bn (compared with Apr–Jun 2025).
Earnings per share were Rs 14.32, against Rs 13.87 a year earlier. The company reported a dividend of Rs 10.00 per share for the quarter.
At Rs 673.39, HALEON trades at 12.7 times earnings, with a dividend yield of 4.2%.
- P/E ratio
- 12.7
- Dividend yield
- 4.2%
- Dividend payout
- 70%
- of earnings
- Return on equity
- 41%
- Net margin
- 16.0%
- trailing twelve months
- Debt to equity
- 0.02
HALEON quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 10.1bn | Rs 1.7bn | 16.6% | Rs 14.32 | Rs 10.00 |
| Jan–Mar 2026 | Rs 9.6bn | Rs 1.5bn | 15.9% | Rs 13.03 | — |
| Oct–Dec 2025 | Rs 10.9bn | Rs 1.8bn | 16.4% | Rs 15.27 | Rs 15.00 |
| Jul–Sep 2025 | Rs 10.6bn | Rs 1.6bn | 15.3% | Rs 13.80 | Rs 5.00 |
| Apr–Jun 2025 | Rs 11.6bn | Rs 1.6bn | 14.0% | Rs 13.87 | Rs 10.00 |
| Jan–Mar 2025 | Rs 10.0bn | Rs 1.3bn | 13.4% | Rs 11.51 | — |
| Oct–Dec 2024 | Rs 9.7bn | Rs 1.4bn | 14.2% | Rs 11.75 | Rs 15.00 |
| Jul–Sep 2024 | Rs 9.8bn | Rs 1.3bn | 13.6% | Rs 11.36 | Rs 5.00 |
HALEON annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 43.1bn | Rs 6.4bn | Rs 54.45 | Rs 30.00 |
| Year to Dec 2024 | Rs 37.2bn | Rs 4.6bn | Rs 39.11 | Rs 20.00 |
| Year to Dec 2023 | Rs 31.6bn | Rs 995.0mn | Rs 8.51 | — |
| Year to Dec 2022 | Rs 27.5bn | Rs 325.0mn | Rs 2.78 | — |
| Year to Dec 2021 | Rs 24.2bn | Rs 2.1bn | Rs 18.23 | — |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 30.5bn
- Shareholders' equity
- Rs 16.2bn
- Cash & bank
- Rs 3.0bn
- Total debt
- Rs 250.0mn
- Current ratio
- 1.55
- 3-month high
- Rs 820.83
- 3-month low
- Rs 673.39
- 1-month change
- -7.5%
- 3-month change
- -16.7%
Read more about HALEON
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
HALEON: common questions
What is HALEON's share price?
Haleon Pakistan Ltd (HALEON) last closed at Rs 673.39 on the Pakistan Stock Exchange.
Does HALEON pay a dividend?
Yes. Haleon Pakistan Ltd paid Rs 30.00 per share for the year to Dec 2025, and the stock's dividend yield is 4.2%.
What were HALEON's latest results?
In the Apr–Jun 2026 quarter, HALEON's sales fell 13% to Rs 10.1bn, from Rs 11.6bn, and profit after tax rose 3% to Rs 1.7bn, from Rs 1.6bn (compared with Apr–Jun 2025).
What is HALEON's P/E ratio?
At Rs 673.39, HALEON trades at 12.7 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.